SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Grunenthal says anti-crush tech Endo uses for Opana ER helps prevent abuse

Grunenthal has reiterated the benefits of its anti-crush intac tech after licensee Endo withdrew its request to have Opana ER labelled as “abuse deterrent."

API firm Unimark Remedies warned by US FDA about Indian plants

The US FDA has warned API manufacturer Unimark Remedies about unsanitary conditions at its facility in Vapi and Bavla in India.

update - Hospira regrets non-compliance

Pfizer unit Hospira and Napp broke APBI code during Remsima push

Pfizer’s Hospira unit and Napp Pharmaceuticals broke ABPI rules covering the promotion of biosimilar medicines according to the UK industry group.

CPhI South Korea

Korea positioned to be global biopharma powerhouse, says industry association

Stem cells and biosimilars are driving the Korean pharma market, according to the country’s Biomedicine Industry Association KoBIA.

CMO contracts will transfer to Pfizer

Pfizer to buy AstraZeneca's antibiotic business in deal worth up to $1.5bn

Pfizer will buy most of AstraZeneca’s antibiotics business in a $1.5bn deal that will see the Anglo-Swedish drug firm continue to package Merrem at its Macclesfield, UK plant for at least the next 18 months.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...